Encyclopedic Reference of Cancer, 1st Edition

  • Published By:
  • ISBN-10: 3540306838
  • ISBN-13: 9783540306832
  • Grade Level Range: College Freshman - College Senior
  • 992 Pages | eBook
  • Original Copyright 2007 | Published/Released November 2007
  • This publication's content originally published in print form: 2007

  • Price:  Sign in for price

About

Overview

The Encyclopedia of Cancer,Second Edition, provides rapid access to focused information on all topics of cancer research for clinicians, research scientists and advanced students. Given the overwhelming success of the first edition, which appeared in 2001, and fast development in the different fields of cancer research, it has been decided to publish a second fully revised and expanded edition, following the principle concept of the first edition that has proven so successful.

Recent developments are seeing a dynamic merging of basic and clinical science, with translational research increasingly becoming a new paradigm in cancer research. The merging of different basic and clinical science disciplines towards the common goal of fighting against cancer has long ago called for the establishment of a comprehensive reference source both as a tool to close the language gap between clinical and basic science investigators and as a platform of information for students and informed laymen alike.

While the First Edition had featured scholarly contributions from approximately 300 scientists/clinicians in one Volume, the Second Edition includes more than 1.000 contributors in 4 Volumes with an A-Z format of more than 7.000 entries. It provides definitions of common acronyms and short definitions of related terms and processes in the form of keyword entries. In addition to the keyword entries, there are detailed essays, which provide comprehensive information on syndromes, genes and molecules, and processes and methods. Each essay is well-structured, with extensive cross-referencing between all entries.

Table of Contents

Front Cover.
Half Title Page.
Other Frontmatter.
Title Page.
Copyright Page.
Preface.
List of Contributors.
1: AACR.
2: AAV.
3: ABC Transporter.
4: ABL.
5: Accelerated Senescence.
6: Achaete-Scute.
7: Acidosis.
8: Acini.
9: Acquired Mutation.
10: Acrocentric Chromosome.
11: Acromegaly.
12: ACTH.
13: Activating Mutation.
14: Acute Cellular Rejection.
15: Acute Lymphoblastic Leukemia.
16: Acute Lymphocytic Leukemia.
17: Acute Lymphoid Leukemia.
18: Acute Promyelocytic Leukemia (APL).
19: Acute Vascular Rejection.
20: Adaptive Response.
21: Adducts.
22: Adducts to DNA.
23: Adenocarcinoma.
24: Adenoma-Carcinoma Sequence.
25: Adenomatous Polyps.
26: Adenoviral Vector.
27: Adenovirus.
28: Adenylyl Cyclase.
29: ADH.
30: Adherens Junctions.
31: Adhesion.
32: Adhesion Molecules.
33: Adjuvant Therapy.
34: Adoptive Immunotherapy.
35: Adrenal Medulla.
36: AFB1.
37: Aflatoxin B1.
38: Aflatoxins.
39: AFP.
40: AKAPS.
41: AKR.
42: AKT.
43: AKT Signal Transduction Pathway in Oncogenesis.
44: ALA.
45: Aldehyde Dehydrogenase.
46: Aldo-Keto Reductase.
47: ALL.
48: Alleles.
49: Allelic Loss.
50: Allograft.
51: α-Fetoprotein.
52: α-Interferon.
53: ALPS.
54: Alternative Lengthening of Telomeres.
55: Alternative Splicing.
56: Alu Elements.
57: Alu Family.
58: Amino Acid Single Letter Code.
59: 5-Aminolevulinic Acid.
60: Aminopeptidase.
61: AML.
62: AML-1.
63: AML-1/ETO/CBFβ/TEL in Chromosomal Translocations.
64: Amplification.
65: Amplified.
66: A-MYB.
67: Anchorage Dependence.
68: Androgen Signaling Pathway.
69: Anemia.
70: Aneuploid.
71: Aneuploidy.
72: Angiogenesis.
73: Annealing.
74: Anoikis.
75: Anoxia.
76: Ansomia.
77: Anthracycline.
78: Antibody.
79: Antiestrogen.
80: Antigen.
81: Antigen Processing.
82: Antigen Retrieval.
83: Antigen-Presenting Cells.
84: Antioxidant Defences.
85: Antisense DNA Therapy.
86: Antisense Nucleic Acid.
87: AP.
88: AP-1.
89: AP-2.
90: AP2.
91: APAF-1.
92: APAF-3.
93: APC.
94: APC Gene in Familial Adenomatous Polyposis.
95: APC/β-Catenin Pathway.
96: Aphidicolin.
97: API3.
98: APL.
99: APO-1.
100: Apopain.
101: Apoptosis.
102: APT1.
103: Apudoma.
104: ARE.
105: ARF.
106: Argentaffinoma.
107: Aromatase.
108: Asbestos.
109: ASCO.
110: ASK1.
111: Askin Tumor.
112: Association Genetics.
113: Astrocytic Tumor.
114: Astrocytoma.
115: AT/RT.
116: Ataxia Telangiectasia.
117: ATM Protein.
118: Atonal Family.
119: ATR.
120: Atrophic Gastritis.
121: ATRX.
122: Atypia.
123: Autocrine.
124: Autocrine Stimulation.
125: Autograft.
126: Autoimmune Disease.
127: Autoimmune Lymphoproliferative Syndrome.
128: Autonomic Nervous System.
129: Autophagosome.
130: Autophagy.
131: Autophosphorylation.
132: Autosomes.
133: Aza-Arenes.
134: BAC.
135: Baculovirus IAP Repeat.
136: BAD.
137: BAGE.
138: Bak1.
139: Balanced Translocation.
140: Band.
141: Barrett Adenocarcinoma.
142: Barrett Esophagus.
143: Basal Cell Carcinoma.
144: Basal Cell Nevus Syndrome.
145: Base Pair.
146: Basement Membrane.
147: BAX.
148: BCC.
149: BCDF.
150: B-cell Differentiation Factor.
151: B-cell Diseases of the Immunopoiesis.
152: B-cell Non-Hodgkin Lymphomas.
153: B-cell Stimulating Factor-2.
154: B-cell Tumours.
155: BCG.
156: BCL-2.
157: BCL2L.
158: BCL2L1.
159: BCL2L7.
160: BCL2-Like 1.
161: BCL6.
162: BCL6 Translocations in B-cell Tumors.
163: BCL2L8.
164: BCL-X.
165: BCL-XL.
166: BCL-XS.
167: BCNS.
168: BCR-ABL1.
169: Beckwith-Wiedemann Syndrome Associated Childhood Tumours.
170: Beclin1.
171: Becn1.
172: Benign Tumor.
173: Berlin Breakage Syndrome.
174: Betel Quid.
175: BHD Syndrome.
176: BHLH.
177: BID.
178: BIK.
179: Bilateral A coustic Neurofibromatosis.
180: A Biological Marker.
181: Biologically Effective Dose.
182: Biomarkers.
183: Biomonitoring.
184: Bioreductive Drug.
185: Biosynthesis.
186: BIR.
187: BIRC4.
188: Birt Hogg Dube Syndrome.
189: B-K Mole Syndrome.
190: Bladder Cancer.
191: Blast Crisis.
192: Bloom Syndrome.
193: B Lymphocytes.
Front Cover.
Half Title Page.
Other Frontmatter.
Title Page.
Copyright Page.
Preface.
List of Contributors.
1: AACR.
2: AAV.
3: ABC Transporter.
4: ABL.
5: Accelerated Senescence.
6: Achaete-Scute.
7: Acidosis.
8: Acini.
9: Acquired Mutation.
10: Acrocentric Chromosome.
11: Acromegaly.
12: ACTH.
13: Activating Mutation.
14: Acute Cellular Rejection.
15: Acute Lymphoblastic Leukemia.
16: Acute Lymphocytic Leukemia.
17: Acute Lymphoid Leukemia.
18: Acute Promyelocytic Leukemia (APL).
19: Acute Vascular Rejection.
20: Adaptive Response.
21: Adducts.
22: Adducts to DNA.
23: Adenocarcinoma.
24: Adenoma-Carcinoma Sequence.
25: Adenomatous Polyps.
26: Adenoviral Vector.
27: Adenovirus.
28: Adenylyl Cyclase.
29: ADH.
30: Adherens Junctions.
31: Adhesion.
32: Adhesion Molecules.
33: Adjuvant Therapy.
34: Adoptive Immunotherapy.
35: Adrenal Medulla.
36: AFB1.
37: Aflatoxin B1.
38: Aflatoxins.
39: AFP.
40: AKAPS.
41: AKR.
42: AKT.
43: AKT Signal Transduction Pathway in Oncogenesis.
44: ALA.
45: Aldehyde Dehydrogenase.
46: Aldo-Keto Reductase.
47: ALL.
48: Alleles.
49: Allelic Loss.
50: Allograft.
51: α-Fetoprotein.
52: α-Interferon.
53: ALPS.
54: Alternative Lengthening of Telomeres.
55: Alternative Splicing.
56: Alu Elements.
57: Alu Family.
58: Amino Acid Single Letter Code.
59: 5-Aminolevulinic Acid.
60: Aminopeptidase.
61: AML.
62: AML-1.
63: AML-1/ETO/CBFβ/TEL in Chromosomal Translocations.
64: Amplification.
65: Amplified.
66: A-MYB.
67: Anchorage Dependence.
68: Androgen Signaling Pathway.
69: Anemia.
70: Aneuploid.
71: Aneuploidy.
72: Angiogenesis.
73: Annealing.
74: Anoikis.
75: Anoxia.
76: Ansomia.
77: Anthracycline.
78: Antibody.
79: Antiestrogen.
80: Antigen.
81: Antigen Processing.
82: Antigen Retrieval.
83: Antigen-Presenting Cells.
84: Antioxidant Defences.
85: Antisense DNA Therapy.
86: Antisense Nucleic Acid.
87: AP.
88: AP-1.
89: AP-2.
90: AP2.
91: APAF-1.
92: APAF-3.
93: APC.
94: APC Gene in Familial Adenomatous Polyposis.
95: APC/β-Catenin Pathway.
96: Aphidicolin.
97: API3.
98: APL.
99: APO-1.
100: Apopain.
101: Apoptosis.
102: APT1.
103: Apudoma.
104: ARE.
105: ARF.
106: Argentaffinoma.
107: Aromatase.
108: Asbestos.
109: ASCO.
110: ASK1.
111: Askin Tumor.
112: Association Genetics.
113: Astrocytic Tumor.
114: Astrocytoma.
115: AT/RT.
116: Ataxia Telangiectasia.
117: ATM Protein.
118: Atonal Family.
119: ATR.
120: Atrophic Gastritis.
121: ATRX.
122: Atypia.
123: Autocrine.
124: Autocrine Stimulation.
125: Autograft.
126: Autoimmune Disease.
127: Autoimmune Lymphoproliferative Syndrome.
128: Autonomic Nervous System.
129: Autophagosome.
130: Autophagy.
131: Autophosphorylation.
132: Autosomes.
133: Aza-Arenes.
134: BAC.
135: Baculovirus IAP Repeat.
136: BAD.
137: BAGE.
138: Bak1.
139: Balanced Translocation.
140: Band.
141: Barrett Adenocarcinoma.
142: Barrett Esophagus.
143: Basal Cell Carcinoma.
144: Basal Cell Nevus Syndrome.
145: Base Pair.
146: Basement Membrane.
147: BAX.
148: BCC.
149: BCDF.
150: B-cell Differentiation Factor.
151: B-cell Diseases of the Immunopoiesis.
152: B-cell Non-Hodgkin Lymphomas.
153: B-cell Stimulating Factor-2.
154: B-cell Tumours.
155: BCG.
156: BCL-2.
157: BCL2L.
158: BCL2L1.
159: BCL2L7.
160: BCL2-Like 1.
161: BCL6.
162: BCL6 Translocations in B-cell Tumors.
163: BCL2L8.
164: BCL-X.
165: BCL-XL.
166: BCL-XS.
167: BCNS.
168: BCR-ABL1.
169: Beckwith-Wiedemann Syndrome Associated Childhood Tumours.
170: Beclin1.
171: Becn1.
172: Benign Tumor.
173: Berlin Breakage Syndrome.
174: Betel Quid.
175: BHD Syndrome.
176: BHLH.
177: BID.
178: BIK.
179: Bilateral A coustic Neurofibromatosis.
180: A Biological Marker.
181: Biologically Effective Dose.
182: Biomarkers.
183: Biomonitoring.
184: Bioreductive Drug.
185: Biosynthesis.
186: BIR.
187: BIRC4.
188: Birt Hogg Dube Syndrome.
189: B-K Mole Syndrome.
190: Bladder Cancer.
191: Blast Crisis.
192: Bloom Syndrome.
193: B Lymphocytes.